Kimberly-Clark/Kenvue: Brussels Expected to Approve Tie-Up with Remedies in Phase 1, Sources Say

The European Commission is expected to approve Kimberly-Clark’s (KMB) $48.7 billion proposed acquisition of Kenvue, with remedies, having so far found that the overlap between the companies’ portfolios does not raise significant competition concerns, according to sources familiar with the matter

Published on Sep 15, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.